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Informatics External Quality Assurance (IEQA) Down Under: evaluation of a pilot
implementation
Abstract
External quality assurance (EQA) provides ongoing evaluation to verify that laboratory medicine results
conform to quality standards expected for patient care. While attention has focused predominantly on
test accuracy, the diagnostic phases, consisting of pre- and post-laboratory phases of testing, have thus
far lagged in the development of an appropriate diagnostic-phase EQA program. One of the challenges
faced by Australian EQA has been a lack of standardisation or "harmonisation" resulting from variations in
reporting between different laboratory medicine providers. This may introduce interpretation errors and
misunderstanding of results by clinicians, resulting in a threat to patient safety. While initiatives such as
the Australian Pathology Information, Terminology and Units Standardisation (PITUS) program have
produced Standards for Pathology Informatics in Australia (SPIA), conformity to these requires regular
monitoring to maintain integrity of data between sending (laboratory medicine providers) and receiving
(physicians, MyHealth Record, registries) organisations' systems. The PITUS 16 Informatics EQA (IEQA)
Project together with the Royal College of Pathologists of Australasia Quality Assurance Programs
(RCPAQAP) has created a system to perform quality assurance on the electronic laboratory message
when the laboratory sends a result back to the EQA provider. The purpose of this study was to perform a
small scale pilot implementation of an IEQA protocol, which was performed to test the suitability of the
system to check compliance of existing Health Level-7 (HL7 v2.4) reporting standards localised and
constrained by the RCPA SPIA. Here, we present key milestones from the implementation, including: (1)
software development, (2) installation, and verification of the system and communication services, (3)
implementation of the IEQA program and compliance testing of the received HL7 v2.4 report messages,
(4) compilation of a draft Informatics Program Survey Report for each laboratory and (5) review
consisting of presentation of a report showing the compliance checking tool to each participating
laboratory.
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Abstract: External quality assurance (EQA) provides ongoing evaluation to verify that laboratory medicine results
conform to quality standards expected for patient care.
While attention has focused predominantly on test accuracy, the diagnostic phases, consisting of pre- and postlaboratory phases of testing, have thus far lagged in the
development of an appropriate diagnostic-phase EQA program. One of the challenges faced by Australian EQA has
been a lack of standardisation or “harmonisation” resulting from variations in reporting between different laboratory medicine providers. This may introduce interpretation
errors and misunderstanding of results by clinicians, resulting in a threat to patient safety. While initiatives such as the
Australian Pathology Information, Terminology and Units
Standardisation (PITUS) program have produced Standards
for Pathology Informatics in Australia (SPIA), conformity to
these requires regular monitoring to maintain integrity of
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data between sending (laboratory medicine providers) and
receiving (physicians, MyHealth Record, registries) organisations’ systems. The PITUS 16 Informatics EQA (IEQA)
Project together with the Royal College of Pathologists of
Australasia Quality Assurance Programs (RCPAQAP) has
created a system to perform quality assurance on the electronic laboratory message when the laboratory sends a
result back to the EQA provider. The purpose of this study
was to perform a small scale pilot implementation of an
IEQA protocol, which was performed to test the suitability
of the system to check compliance of existing Health Level-7
(HL7 v2.4) reporting standards localised and constrained
by the RCPA SPIA. Here, we present key milestones from
the implementation, including: (1) software development,
(2) installation, and verification of the system and communication services, (3) implementation of the IEQA program
and compliance testing of the received HL7 v2.4 report messages, (4) compilation of a draft Informatics Program Survey Report for each laboratory and (5) review consisting of
presentation of a report showing the compliance checking
tool to each participating laboratory.
Keywords: external quality assurance (EQA); Informatics EQA; interoperability conformance testing; laboratory
medicine report standardisation; messaging; patient safety.

Introduction
Researchers from the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) and Macquarie University recently published a paper describing
the importance of pre- and post-laboratory phases which
form the diagnostic phases of laboratory medicine testing
[1]. The issues, however, have been known of in Australia
since at least 1996 [2]. These phases “beyond the lab”
constitute a major source of errors that reduce laboratory
effectiveness and threaten patient safety [1, 3]. External
quality assurance (EQA) ensures that verification is performed on a recurring basis, and that laboratory results
conform to expectations for quality required for patient
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care [4]; however, most Australian laboratories have previously focused narrowly on laboratory processes such as
test accuracy and precision [1]. Until recently, it was very
difficult to quantify the number and magnitude of errors
in the extra-analytical phases due to a lack of formal EQA
measures in these areas.
Detection of these errors requires reliable quality indicators during the total testing process (TTP), from the time
the laboratory request is determined, until the clinician
receives the final report, makes a diagnosis and decides on
the appropriate action [3, 5, 6]. Launched in 2008, the Key
Incident Monitoring and Management System (KIMMS)
is an Australasian-developed quality improvement (QI)
program that records incidents (process defects) and episodes (occasions where incidents may occur) while also
assigning quantified risk to each incident type (by multiplying by harm rating and detection difficulty score) using
failure mode effects analysis (FMEA) [5]. By 2016 KIMMS
had detected over 200 million episodes and 2.9 million
incidents, detecting an overall TTP incident rate of 1.75%
[5]. Some incident rates may appear low, but when taking
into account risks and their frequencies, critical incident
types emerge that require improvements in management.
For example, haemolysis had both the highest incidence
(22.6% of total incidents) and highest risk (26.68% of total
risk). However, incidents that have low frequency (e.g.
“sample suspected to be from wrong patient” had the
second lowest score) but high harm rating (e.g. 10/10) and
detection difficulty scores (10/10) end up having a relatively higher risk to reflect the severity of potential risk to
the patient [5]. Until recently, KIMMS has focused mainly
on the pre-laboratory phase of the TTP cycle, thus there
has been a need to create an EQA program that encompasses the post-laboratory phase.
One of the major post-laboratory areas that has been
under urgent pressure for improved EQA measures has
been laboratory reporting, especially given the widespread adoption of electronic health records which aggregate reports from multiple laboratories, such as MyHealth
Record in Australia [7]. The importance for standardisation or “harmonisation” of the formats and styles used in
clinical chemistry reporting is key to interoperability and
safety for electronic health records [8–10]. Significant variations in reporting policies between different Australian
laboratory medicine providers, or even within the same
provider, result in different styles of reports for different
customers [11]. The clinical chemistry report needs to be
clear and unambiguous; however, in Australia there are
still differences in reporting, e.g. different names for the
same test, different units, different tests included in panels
with the same names, differences in reference intervals

(RIs) and flagging of results outside limits [12]. These differences may introduce misunderstanding resulting in
interpretation errors by clinicians or patients at the postlaboratory phase [10, 13], which is a patient safety issue.
Activities aiming to increase harmonisation in laboratory
medicine include improving metrological comparability
of results, as well as reducing unnecessary between-laboratory variation in test requesting and reporting [9], which
is the focus of our trial.
The Australian Pathology Units and Terminology
Standardisation (APUTS) project [12] began in 2011 and
was the first of three projects completed in a program of
laboratory medicine informatics standardisation led by
the RCPA but which had active involvement from many
organisations and individuals. The program is now called
PITUS (Pathology Information Terminology and Units
Standardisation) – a fourth phase has been planned but
awaits funding. The consensus standards developed in
PITUS have been endorsed and published by the RCPA
as college policy – the version at the time of writing was
called Standards for Pathology Informatics in Australia
(SPIA) v3.0 [14, 15]. It includes requesting and reporting
terminology including preferred Australian terms, standardised units, safe report rendering, information models
and harmonised RIs and best practice guidance for safe
laboratory medicine requesting and reporting. One of
the six sub-projects for PITUS 16 was a trial implementation of an Informatics EQA (IEQA) program, therefore the
purpose of this study was to evaluate a small scale pilot
implementation of an IEQA program in order to study the
feasibility for large scale implementation. This sub-project
endeavoured to create a system to perform quality assurance on the electronic laboratory message when the laboratory sends a result back to the EQA provider itself. This
was a follow-on to a previous (PITUS-14) sub project which
investigated a more manual evaluation of instances of the
implementation of standards for requesting and reporting
working with the largest private and largest public laboratories in Australia and with active co-operation from the
Medical Software Industry Association and the National
EHealth Transition Authority [8, 11, 16].

Pre- and post-laboratory errors
Pre- and post-laboratory errors may have serious consequences for patients and place unnecessary cost on the
medical system. Pre-laboratory errors include errors
in ordering tests, preparing patients and processing
samples, and post-laboratory errors may occur during
reporting results to physicians, interpretation of results
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by physicians, notification of results to patients, administration and communication [17]. A study by the American
Academy of Family Physicians reported that at least 18% of
patients experienced some form of harm in a study of 966
pre- and post-laboratory errors [17]. In addition to harm,
further outcomes included delays in care (24%), financial
consequences and time wasted (22%), pain and suffering
(11%) and adverse clinical consequence (2%) [17].
An Australian study has outlined performance criteria
for the post-laboratory phase, highlighting a need for the
post-laboratory phase to take “quality technical results
and provide the means for clinical interpretation in the
report” [18]. For example, RIs are often used in interpretation particularly at diagnosis, but different laboratories
may use different RIs, even in cases of similar methods
[18, 19]. An evidence-based approach was developed by
scientific consensus at workshops of the Australasian
Association of Clinical Biochemists (AACB) between 2012
and 2014, resulting in the development of the “AACB Harmonised Reference Intervals” [19]. While laboratories
were consulted, adoption of RIs still lies with each laboratory. Reaching harmonisation would result in consistency of RIs across Australia and New Zealand. Sikaris has
expanded on the ISO15189 standard definition of postlaboratory phase (the processes following the examination, including review of results) [20] to incorporate the
quality of clinical chemistry reports, including formatting,
releasing, reporting and retention of examination results
for future access [18]. It is also recommended that quality
in post-laboratory interpretation should take into account
not only quality analytical data, but also its interpretation
against the patient’s clinical context [18]. This is crucial
because the misinterpretation of test results may have
many contributors, namely cognitive factors, RIs, clinical
interpretations and notifications from laboratory specialists, all of which may contribute to misdiagnosis [21–23].

An Informatics EQA (IEQA) program
for the post-laboratory phases
With physicians often receiving clinical chemistry reports
electronically from different laboratories, there is a risk
that variations in reporting formats may add a layer of
complexity in interpreting the report, or result in errors
which can result in a risk to patient safety [24]. Audit and
dissemination of harmonisation guidelines on their own
have been shown to be insufficient in managing quality
of results interpretation in general practice, and EQA
studies have shown variability between clinicians’ interpretation of clinical chemistry results for specific tests
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[25–27]. Therefore, it is crucial that: 1) standards are actually implemented; and 2) conformity to the standards and
guidelines is continuously assessed. The RCPAQAP aims
to implement an IEQA program to ensure ongoing quality
and safety in reporting.

A trial implementation of the IEQA program
Compliance and standardisation of laboratory medicine
terminology are needed to maintain integrity of data
shared between sending (laboratory medicine providers)
and receiving (physicians, MyHealth Record, registries)
organisations’ digital health information systems. The
RCPA PITUS 16 Project Working Group 6 collaborated with
RCPAQAP to design and analyse a system for reporting
data using an IEQA program, the architecture of which is
outlined in Figure 1.
In 2015, as part of the RCPAQAP Liquid Serum Chemistry (LSC), program, laboratories were invited to supply a
routine paper report displaying results. The LSC program
is a commutable frozen patient serum program used to
assess method differences. The RCPAQAP then analysed
these reports against the SPIA (formerly known as the
RCPA APUTS v2.3 standard) [28], and variations were identified [29]. This provided validation for the rationale for
development and trial of an IEQA protocol to test compliance of existing Health Level-7 (HL7) reporting standards
with reporting standards developed by the RCPA [1, 30].
Accrediting bodies such as the National Association of
Testing Authorities, Australia (NATA) could then use this
to assist with compliance. Medical Objects Pty Ltd [31], a
medical software vendor, was selected after formal evaluation of responses to a call for expressions of interest. The
evaluation software was co-designed. The system built
was capable of sending standardised electronic request
messages and receiving electronic report messages and
then analysing the message received. Message services
supported Secure Message Delivery (SMD)-based secure
messaging. Two laboratories volunteered to send HL7 v2
report messages with atomic clinical chemistry results
for the RCPAQAP LSC program. These sites represented
two of the major laboratory information systems (LIS) in
use in Australia and serviced both hospital and community patients and hence were sending results to multiple
Hospital Information Systems and General Practitioner
practice systems. The Medical Objects’ software tool was
used by RCPAQAP to test compliance of the HL7 v2 report
messages received from each laboratory against the HL7
Messaging Standard Version 2.4 [32], Australian Standard AS4700.2:2012 [33] and RCPA APUTS v2.3 standards
Unauthenticated
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Laboratory

RCPA QAP

Request for testing
Co-ordination

Report of IVD findings
KIMMS program

Informatics EQA
program

Report
of MCT

IVD EQA
request receipt

IVD testing in
department

Informatics testing
Message
conformance testing
Standards

IVD EQA program
Report of IVD findings

NPAAC
Standards Australia
RCPA policy

Figure 1: High-level IEQA architecture. IVD, in vitro diagnostic; MCT, message conformance testing.

[34] (an earlier version of SPIA [28] but with most of the
same compliance points). A mock RCPAQAP Informatics
Program Survey Report was designed and then compiled
for each of the laboratories, reporting on an assessment
of the validity, integrity and rendered form of the data
received.

Key milestones of the IEQA trial
Key milestones of the IEQA trial are listed and described
in Table 1.

Issues around the implementation
In the IEQA trial, the participating laboratories were
sent and could receive the electronic request message,
but their LIS were not configured to process it. Electronic
laboratory requesting was not the main focus of the trial
and although electronic laboratory requesting is technically possible, more work is required by the RCPAQAP
to find the best solution for how to communicate the
60+ systematized nomenclature of medicine-clinical
terms Australia codes for the individual analytes of the
RCPAQAP LSC program in an electronic request message.

Participating laboratories would also need to configure
their laboratory information system to process these
codes.
As for other EQA programs the IEQA still needs a
subject matter expert to be involved in running the EQA
round. In this case that means a laboratory medicine
informatician familiar with messaging standards and
reporting requirements.
The lack of a significant industry driver to encourage
laboratories to configure their LIS to receive a standardised electronic request message remains a barrier. This
barrier would be overcome if there was an IEQA in place
to identify those laboratories that were not using the SPIA
standards.
Another issue is that patients have the freedom to
select which collection centre they have their samples collected, and that collection centre may not belong to the
laboratory suggested by the requestor. The lack of a centralised laboratory medicine order message broker means
there is no direct link between requestors (e.g. physicians)
and the laboratory performing the service. The adoption
of standards for laboratory medicine informatics by the
clinical chemistry accreditation scheme [National Pathology Accreditation Advisory Council (NPAAC)] and/or for
requesting a common request hub would drive standardisation in the right direction.

Unauthenticated
Download Date | 5/28/19 5:12 AM

Hardie et al.: IEQA Down Under

301

Table 1: Key milestones of the IEQA trial.
Key milestone

Stages

1. Development of the
software by Medical
Objects. Two new
software modules for
the trial implementation,
including:

1. Multi-component test requests (e.g. liver function test) (electronic requesting of clinical chemistry
request orders)
2. Quality assurance-compliance rule checking module for HL7 v2.4 report messages against HL7
Messaging Standard v2.4 and AS4700:2:2012 standard; atomic data in HL7 v2.4 report messages
against SPIA, including checking LOINC code, preferred term, reference interval, flagging, alignment
and units

2. Installation, setup
and verification of the
system software and
communication services

a) M
 edical Objects “Explorer” software application installed on computers used for compliance testing
b) Medical Objects’ “Eclipse” communication services used during the trial implementation to
electronically send HL7 v2.4 request messages to the participating laboratories as well as receive
HL7 v2.4 report messages from the participating laboratories

3. Implementation of
the IEQA program and
compliance testing of the
received HL7 v2.4 report
messages

a) U
 sing bulk orders module, a clinical chemistry test request for Liquid Serum Chemistry program was
created and an electronic HL7 v2.4 request was electronically transmitted to the two laboratories.
Also sent a PDF version of clinical chemistry request form via email
b) The participating laboratories electronically transmitted HL7 v2.4 report messages with the results
to RCPAQAP for analysis
c) Q
 uality assurance module performed compliance rule checks on each received HL7 v2.4 report
messages. Assessed
a. Compliance of HL7 v2.4 report message against the HL7 Messaging Standard v2.4 and AS4700.2:
2012 standard, including compliance to conformance points in the AS4700:2:2012 standard
b. Compliance of atomic result data in the HL7 v2.4 report messages against terminology standards
(LOINC code, preferred term, reference interval and units) and harmonised reference intervals
described within SPIA [15] (Figure 2)
c. I n the quality assurance module, windows were also provided for the tester to perform manual
comparison of the rendered clinical chemistry report against the expected SPIA format, which is
important for certain SPIA standards that require manual checking (Figure 3)

4. Compilation of a draft
Informatics Program
Survey Report

a) These were provided to each laboratory that participated, to assist them in identifying compliant
areas and areas requiring further improvement

5. Review of trial
implementation

a) P
 resentation of report showing the compliance checking tool to each participating laboratory

LOINC, Logical Observation Identifiers Names and Codes.

Figure 2: Example of compliance rule check for the atomic result data against the RCPA published SPIA.

Unauthenticated
Download Date | 5/28/19 5:12 AM

302

Hardie et al.: IEQA Down Under

Figure 3: Example of quality assurance software windows, with report format using SPIA rendered report rules (left) and rendered clinical
chemistry report from the HL7 v2.4 report message (right).

Use of ICT to support EQA in diagnostic phase
and following up test results – does information technology (IT) enhance follow-up?

Conclusions

records. This paper demonstrates the feasibility of an
IEQA program supported by ICT which has the potential
to be used by accrediting bodies to assist with compliance
with PITUS standards and HL7 v2 messaging. This is a
multi-step process which first drives standardisation and
that in turn reduces variation which in turn reduces error
and thereby harm. Expansion of this IEQA program to a
large scale implementation across Australia will reveal its
true benefits in improving communication, standardisation and patient safety in laboratory medicine in the era of
electronic health records.
The described IEQA model could be used in any
country where there is electronic transmission of requests
and results. In Australia, there are guidelines for the
format of reports and the transmission of results, these
would need to be in place as well. This is a key initiative
to reduce this under-recognised post-laboratory error. We
believe that EQA providers in each country could develop
a similar IEQA in the interests of patient safety.

For laboratory medicine services to provide quality
post-laboratory services to clinicians and patients, it is
essential that programs are in place to ensure ongoing
proficiency of test result reporting as well as standardisation of test results. Removing barriers to interoperability,
both between sending (laboratories) and receiving (clinicians, MyHealth Record, patients or registries) organisations is particularly important with the implementation
of laboratory medicine reports into electronic health
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Medical Objects and Ray Oreo of RCPAQAP. ML and DM
undertook the manual aspects of the conformance testing
and the subsequent IEQA reporting.
Author contributions: All the authors have accepted
responsibility for the entire content of this submitted
manuscript and approved submission.

Our team’s previous research has demonstrated that
health Information and Communications Technology
(ICT) can be used to support EQA by standardised result
reporting, but it can also be useful in other clinical applications. For example, electronic test acknowledgement
systems may help to reduce incidence of missed test
results [35] and electronic decision support systems can
be used to improve the quality of result interpretation, by
alerts specific to the patient on adhering to clinical guidelines or protocols [36]. Thus, we believe that it is feasible
to use EQA to study compliance to standards on requesting and reporting lab tests.
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